proxyvotesnow.com

Home › Asset managers › Goldman Sachs › 2025-2026 › Against the board

Goldman Sachs 2025-2026: where it broke with the board

At least 6,000 proposals in the 2025-2026 proxy season: Goldman Sachs voted against, or withheld its votes from, at least 6,000 proposals put forward by company boards, and voted for 0 shareholder proposals, by its own Form N-PX filings.

Two kinds of vote are listed: a board-sponsored proposal Goldman Sachs voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.

Everything Only shareholder proposals it backed

6,000 proposals. The board-sponsored half of this list keeps the 6,000 proposals with the most funds behind them; the rest are in the interactive database. Every shareholder proposal it backed is listed in full.

Goldman Sachs, 2025-2026 proxy season. Who put a proposal on the ballot is taken from the filer’s own N-PX answer (Item 1(h)), or, marked “inferred”, from its category and wording where the filing does not say; see how we count these.
CompanyMeetingProposalCategory On the ballot fromBoard recommendedGoldman Sachs votedFunds
MRF Limited March 28, 2026 Approve Revision in the Terms of Remuneration of Rahul Mammen Mappillai as Managing Director Compensation Board AGAINST 2
MRF Limited March 28, 2026 Approve Revision in the Terms of Remuneration of Samir Thariyan Mappillai as Whole-Time Director Compensation Board AGAINST 2
MRF Limited March 28, 2026 Approve Revision in the Terms of Remuneration of Varun Mammen as Whole-Time Director Compensation Board AGAINST 2
Madison Square Garden Sports Corp. December 8, 2025 Election of the following nominees as directors: Anthony J. Vinciquerra Director Elections Board WITHHOLD 2
Madison Square Garden Sports Corp. December 8, 2025 Election of the following nominees as directors: Ivan Seidenberg Director Elections Board WITHHOLD 2
Madison Square Garden Sports Corp. December 8, 2025 Election of the following nominees as directors: Joseph M. Cohen Director Elections Board WITHHOLD 2
Madison Square Garden Sports Corp. December 8, 2025 Election of the following nominees as directors: Nelson Peltz Director Elections Board WITHHOLD 2
Magnite, Inc. June 8, 2026 Election of Class III Directors: David Pearson Director Elections Board AGAINST 2
Magnite, Inc. June 8, 2026 Election of Class III Directors: Doug Knopper Director Elections Board AGAINST 2
Magnite, Inc. June 8, 2026 Election of Class III Directors: Paul Caine Director Elections Board AGAINST 2
Manila Electric Company June 30, 2026 Elect James L. Go as Director Director Elections Board AGAINST 2
Manila Electric Company June 30, 2026 Elect Jose Ma. K. Lim as Director Director Elections Board AGAINST 2
Manila Electric Company June 30, 2026 Elect June Cheryl A. Cabal-Revilla as Director Director Elections Board AGAINST 2
Manila Electric Company June 30, 2026 Elect Lance Y. Gokongwei as Director Director Elections Board AGAINST 2
Manila Electric Company June 30, 2026 Elect Lydia B. Echauz as Director Director Elections Board AGAINST 2
Manila Electric Company June 30, 2026 Elect Patrick Henry C. Go as Director Director Elections Board AGAINST 2
Mao Geping Cosmetics Co., Ltd. April 24, 2026 Approve Grant of General Mandate to the Board to Issue H Shares Capital Structure Board AGAINST 2
Marico Limited August 8, 2025 Approve Enhancement of Limit for Loan, Guarantee and Investment by the Company under Section 186 of the Companies Act, 2013 Capital Structure Board AGAINST 2
Max Healthcare Institute Limited May 11, 2026 Reelect Narayan K. Seshadri as Director Director Elections Board AGAINST 2
Maxscend Microelectronics Co., Ltd. July 16, 2025 Approve Authorization of the Board to Handle All Related Matters Compensation Board AGAINST 2
Maxscend Microelectronics Co., Ltd. July 16, 2025 Approve Draft and Summary of Performance Shares Incentive Plan Compensation Board AGAINST 2
Maxscend Microelectronics Co., Ltd. July 16, 2025 Approve Performance Shares Incentive Plan Implementation Assessment Management Measures Compensation Board AGAINST 2
McDonald's Holdings Co. (Japan) Ltd. March 25, 2026 Approve Allocation of Income, with a Final Dividend of JPY 56 Capital Structure Board AGAINST 2
McDonald's Holdings Co. (Japan) Ltd. March 25, 2026 Approve Bonus Related to Retirement Bonus System Abolition Compensation Board AGAINST 2
McGrath RentCorp June 3, 2026 To approve, in a non-binding vote, the compensation of the Company's named executive officers. Say-on-Pay Board AGAINST 2
Mechanics Bancorp May 28, 2026 To approve, on an advisory (non-binding) basis, the executive compensation of the Company's named executive officers for 2025. Say-on-Pay Board (inferred) AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Adjustment Mechanism Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Attribution of Profit and Loss During the Transition Period Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Authorization of the Board to Handle All Related Matters Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Basis and Fairness of Pricing for This Transaction Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Company's Eligibility for Acquisition by Issuance of Shares Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transactions and Validity of the Submitted Legal Documents Regarding this Transaction Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Conditional Agreement on Acquisition by Issuance of Shares and Profit Forecast Compensation Agreement Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Confidentiality Measures and Confidentiality System Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Description of Any Third-party Organization or Individual Hired Directly or Indirectly for Compensation in This Transaction Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Distribution Arrangement of Undistributed Earnings Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Impact of Dilution of Current Returns on Major Financial Indicators and the Relevant Measures to be Taken Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Purpose and Approach as Well as the Fairness of Pricing Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Issue Size Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Issue Type, Par Value and Listing Exchange Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Lock-up Period Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Overall Transaction Plan Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Pricing Basis, Price Reference Date and Issue Price Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Purchase and Sale of Assets within 12 Months Prior to This Transaction Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Relevant Audit Reports, Review Report and Evaluation Report of This Transaction Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Relevant Parties Do Not Exist Condition Stipulated in Article 12 of Regulatory Guidelines for Listed Companies No. 7 Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Report (Draft) and Summary on Company's Acquisition by Issuance of Shares Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Resolution Validity Period Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Stock Price Fluctuations in the 20 Trading Days Before the Announcement of This Transaction Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Target Asset Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Transaction Complies with Article 4 of Regulatory Guidelines for Listed Companies No. 9 Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Transaction Complies with Articles 11, 43 and 44 of Measures for the Administration of Major Asset Restructuring of Listed Companies Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Transaction Does Not Constitute as Major Adjustment Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Transaction Does Not Constitute as Major Asset Restructuring or Restructuring for Listing Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Transaction Parties Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Transaction Price Extraordinary Transactions Board AGAINST 2
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve the Company Does Not Exist Condition Stipulated in Article 11 of Measures for the Administration of Registration of Securities Issuance by Listed Companies Extraordinary Transactions Board AGAINST 2
Meituan June 26, 2026 Approve PricewaterhouseCoopers as Auditors and Authorize Board to Fix Their Remuneration Audit-related Board AGAINST 2
Menora Mivtachim Holdings Ltd. October 5, 2025 Reelect Eran Griffel as Director Director Elections Board AGAINST 2
Menora Mivtachim Holdings Ltd. October 5, 2025 Reelect Orly Yarkoni as Director and Approve Her Remuneration Director Elections Board AGAINST 2
Menora Mivtachim Holdings Ltd. October 5, 2025 Reelect Regina Ungar as Director and Approve Her Remuneration Director Elections Board AGAINST 2
Menora Mivtachim Holdings Ltd. October 5, 2025 Reelect Shay Feldman as Director and Approve His Remuneration Director Elections Board AGAINST 2
Menora Mivtachim Holdings Ltd. October 5, 2025 Reelect Yoav Shimon Kremer as Director and Approve His Remuneration Director Elections Board AGAINST 2
Menora Mivtachim Holdings Ltd. October 5, 2025 Reelect Yonel Cohen as Director and Approve His Remuneration Director Elections Board AGAINST 2
Merus N.V. December 9, 2025 Non-binding advisory proposal to approve certain compensation arrangements Say-on-Pay Board (inferred) AGAINST 2
Midea Group Co., Ltd. September 24, 2025 Approve General Mandate to Issue Onshore and Offshore Debt Financing Instruments Capital Structure Board AGAINST 2
Midea Group Co., Ltd. September 24, 2025 Approve Provision of Guarantees Capital Structure Board AGAINST 2
Midea Group Co., Ltd. June 5, 2026 Approve General Mandate to Issue Shares Capital Structure Board AGAINST 2
Midea Group Co., Ltd. June 5, 2026 Approve PricewaterhouseCoopers Zhong Tian LLP (Limited Liability Partnership) as Domestic Audit Firm and PricewaterhouseCoopers as Overseas Audit Firm and Authorize Board to Fix Their Remuneration Audit-related Board AGAINST 2
Ming Yang Smart Energy Group Co., Ltd. October 20, 2025 Approve Authorization of the Board to Handle All Related Matters Compensation Board AGAINST 2
Ming Yang Smart Energy Group Co., Ltd. October 20, 2025 Approve Employee Share Purchase Plan Compensation Board AGAINST 2
Ming Yang Smart Energy Group Co., Ltd. October 20, 2025 Approve Implementation Assessment and Management Measures of Stock Option Incentive Plan Compensation Board AGAINST 2
Ming Yang Smart Energy Group Co., Ltd. October 20, 2025 Approve Management Method of Employee Share Purchase Plan Compensation Board AGAINST 2
Ming Yang Smart Energy Group Co., Ltd. October 20, 2025 Approve Stock Option Incentive Plan and Its Summary Compensation Board AGAINST 2
Ming Yang Smart Energy Group Co., Ltd. May 20, 2026 Approve Application of Credit Lines Capital Structure Board AGAINST 2
Ming Yang Smart Energy Group Co., Ltd. May 20, 2026 Approve External Guarantee Capital Structure Board AGAINST 2
MiniMax Group, Inc. June 11, 2026 Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure Board AGAINST 2
MiniMax Group, Inc. June 11, 2026 Authorize Reissuance of Repurchased Shares Capital Structure Board AGAINST 2
Minmetals Capital Co., Ltd. December 15, 2025 Approve Joint Investment with Related Party Extraordinary Transactions Board AGAINST 2
Minmetals Capital Co., Ltd. May 15, 2026 Approve Use of Funds for Entrusted Financial Management Extraordinary Transactions Board AGAINST 2
Mission Produce, Inc. April 9, 2026 ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS To approve the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 2
Mitsubishi Gas Chemical Co., Inc. June 25, 2026 Elect Director Fujii, Masashi Director Elections Board AGAINST 2
Mitsubishi Gas Chemical Co., Inc. June 25, 2026 Elect Director Isahaya, Yoshinori Director Elections Board AGAINST 2
Mitsubishi Motors Corp. June 18, 2026 Elect Director Hiraku, Tomofumi Director Elections Board AGAINST 2
Mitsubishi Motors Corp. June 18, 2026 Elect Director Kakiuchi, Takehiko Director Elections Board AGAINST 2
Mitsubishi Motors Corp. June 18, 2026 Elect Director Kato, Takao Director Elections Board AGAINST 2
Mitsubishi Motors Corp. June 18, 2026 Elect Director Sakamoto, Hideyuki Director Elections Board AGAINST 2
Mitsubishi Motors Corp. June 18, 2026 Elect Director Sasae, Kenichiro Director Elections Board AGAINST 2
Motor Oil (Hellas) Corinth Refineries SA June 17, 2026 Advisory Vote on Remuneration Report Compensation Board AGAINST 2
Motor Oil (Hellas) Corinth Refineries SA June 17, 2026 Approve Advance Payment for Director Remuneration Compensation Board AGAINST 2
Motor Oil (Hellas) Corinth Refineries SA June 17, 2026 Approve Auditors and Fix Their Remuneration Audit-related Board AGAINST 2
Motor Oil (Hellas) Corinth Refineries SA June 17, 2026 Approve Profit Distribution to Board Members and Management Compensation Board AGAINST 2
Motor Oil (Hellas) Corinth Refineries SA June 17, 2026 Approve Profit Distribution to Company Personnel Compensation Board AGAINST 2
Motor Oil (Hellas) Corinth Refineries SA June 17, 2026 Approve Remuneration of Directors Compensation Board AGAINST 2
Motor Oil (Hellas) Corinth Refineries SA June 17, 2026 Elect Directors (Bundled) Director Elections Board AGAINST 2
Motor Oil (Hellas) Corinth Refineries SA June 17, 2026 Elect Members of Audit Committee (Bundled) Director Elections Board AGAINST 2
Mphasis Limited July 24, 2025 Reelect Amit Dalmia as Director Director Elections Board AGAINST 2
MultiChoice Group Ltd. August 27, 2025 Approve Remuneration of Non-executive Directors Compensation Board AGAINST 2
Muyuan Foods Co., Ltd. September 8, 2025 Approve Authorization of the Board to Handle All Matters Related to Key Employee Stock Ownership Plan Compensation Board AGAINST 2
Muyuan Foods Co., Ltd. September 8, 2025 Approve Authorization of the Board to Handle All Matters Related to Operator Stock Ownership Plan Compensation Board AGAINST 2

← Previous Page 30 of 60 Next →

← Back to Goldman Sachs 2025-2026 overview

Built November 7, 2026 from SEC Form N-PX filings.